BRAF Codon 600 Missense | Cancer Search

Details 21 Trials 20 Therapies

mutation class

Small Mutation

synonyms

V600BRAF

BRAF Class I Mutation

Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma

2 sites for NCT02645149

ALK Fusion, +19 more biomarkers

Melanoma, +1 more condition

ceritinib, +4 more drugs

targeted therapy

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

221 sites for NCT04511013

BRAF Codon 600 Missense

Melanoma

binimetinib, +3 more drugs

immunotherapy, +1 more type

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

10 sites for NCT03297606

ABL1 Fusion, +98 more biomarkers

B-Cell Non-Hodgkin Lymphoma, +2 more conditions

axitinib, +15 more drugs

immunotherapy, +1 more type

Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma

39 sites for NCT04417621

BRAF Codon 600 Missense, +1 more biomarker

Cutaneous Melanoma

LTT462, +3 more drugs

targeted therapy

A Study of Alectinib, Entrectinib, Vemurafenib Plus Cobimetinib, or Pralsetinib in Patients With Resectable Stages II-III Non-Small Cell Lung Cancer With ALK, ROS1, NTRK, BRAF V600, or RET Molecular Alterations

20 sites for NCT04302025

ALK Fusion, +7 more biomarkers

Non-Small Cell Lung Carcinoma

alectinib, +8 more drugs

chemotherapy, +4 more types

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

18 sites for NCT04294160

BRAF Codon 600 Missense

Colorectal Carcinoma

dabrafenib, +5 more drugs

immunotherapy, +1 more type

Show 21 Trials for BRAF Codon 600 Missense